SUSPECT PULMONARY FIBROSIS

— a common threat across a wide range of ILDs, including connective tissue diseases (CTDs).1-3  

Pulmonary fibrosis can become a key driver of irreversible harm and early mortality, and calls for urgent identification and intervention.4

Find out more about the Risk
Patient showing a lung scan
Patient showing a lung scan
Patient showing a lung scan
Patient showing a lung scan

HRCT QUIZ

 

What can you uncover from an HRCT scan of a patient with ILD?

Time to complete: approx. 3 minutes

EARLY SCREENING AND MONITORING FOR PULMONARY FIBROSIS CAN HELP MAKE A DIFFERENCE5

Pulmonary fibrosis is a common feature across a wide range of ILDs and CTDs.1-3

FIND OUT MORE ABOUT THE RISK

PROGRESSIVE FIBROSING ILD PHENOTYPE

See what Vincent Cottin, Professor of Respiratory Medicine, has to say about the threat of pulmonary fibrosis across a range of ILDs

THE IMPORTANCE OF HRCT SCANS ON BASELINE

See what Clive Kelly, Senior Lecturer, has to say about the prevalence of pulmonary fibrosis in patients with connective tissue diseases

CTD=connective tissue disease; HRCT=high-resolution computed tomography; ILD=interstitial lung disease

References

  1. 1.

    American Lung Association. Types, causes and risk factors of pulmonary fibrosis https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/pulmonary-fibrosis/introduction/types-causes-and-risk-factors.html. Accessed December 20, 2019.

  2. 2.

    Pulmonary Fibrosis Foundation. What is pulmonary fibrosis? https://www.pulmonaryfibrosis.org/life-with-pf/about-pf. Accessed December 20, 2019.

  3. 3.

    Fisher JH, et al. Baseline characteristics and comorbidities in the Canadian Registry for Pulmonary Fibrosis. BMC Pulm Med 2019;19:233.

  4. 4.

    American Lung Association. Pulmonary fibrosis progression and exacerbation. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/pulmonary-fibrosis/patients/living-well-with-pulmonary-fibrosis/progression-and-exacerbation.html. Accessed December 20, 2019.  

  5. 5.

    Cottin V, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018;27:180076.